Jeddah Health Cluster Two signs a cooperation agreement with Jamjoom Pharma to enhance healthcare
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the leading Saudi companies specializing in the pharmaceutical industry. This partnership aims to enhance health awareness and develop human capabilities within the medical sector in the Kingdom of Saudi Arabia.
This step comes within the framework of the cluster's efforts to support the Kingdom's Vision 2030, which seeks to improve the quality of health services provided to citizens and residents. Through this collaboration, the focus will be on exchanging expertise and knowledge between the public and private sectors to develop innovative pharmaceutical solutions.
The agreement also includes specialized training programs aimed at raising the efficiency of medical personnel working at Jeddah Health Cluster Two. Through these initiatives, both parties seek to improve the patient experience and ensure the provision of the best medicines and therapeutic services in accordance with the highest international standards.
At the conclusion of the agreement, officials from both sides emphasized the importance of this partnership in supporting the local pharmaceutical industry. These efforts are expected to contribute to strengthening pharmaceutical security in the Kingdom and providing a more sustainable and advanced health environment for all members of society.